Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes, Gestational | 62 | 2024 | 1250 | 9.660 |
Why?
|
DNA Methylation | 87 | 2024 | 4392 | 7.210 |
Why?
|
Fetal Blood | 56 | 2024 | 1347 | 6.190 |
Why?
|
Adiposity | 36 | 2024 | 1879 | 5.950 |
Why?
|
Insulin Resistance | 42 | 2024 | 3954 | 4.800 |
Why?
|
Placenta | 31 | 2024 | 1709 | 4.080 |
Why?
|
Blood Glucose | 53 | 2024 | 6390 | 3.910 |
Why?
|
Pregnancy | 187 | 2024 | 29869 | 3.350 |
Why?
|
Prenatal Exposure Delayed Effects | 39 | 2024 | 2518 | 3.310 |
Why?
|
Adiponectin | 19 | 2024 | 1107 | 2.940 |
Why?
|
Hyperglycemia | 14 | 2024 | 1375 | 2.880 |
Why?
|
Fluorocarbons | 15 | 2024 | 492 | 2.800 |
Why?
|
Epigenesis, Genetic | 58 | 2024 | 3794 | 2.770 |
Why?
|
Weight Gain | 17 | 2024 | 2349 | 2.610 |
Why?
|
Glucose Tolerance Test | 32 | 2024 | 1178 | 2.590 |
Why?
|
Birth Weight | 32 | 2024 | 2101 | 2.530 |
Why?
|
Leptin | 15 | 2024 | 1595 | 2.520 |
Why?
|
Body Mass Index | 80 | 2024 | 12942 | 2.450 |
Why?
|
CpG Islands | 25 | 2024 | 1192 | 2.360 |
Why?
|
Diabetes Mellitus, Type 2 | 55 | 2024 | 12143 | 2.090 |
Why?
|
Environmental Pollutants | 19 | 2024 | 1277 | 2.000 |
Why?
|
Alkanesulfonic Acids | 10 | 2024 | 201 | 1.870 |
Why?
|
Absorptiometry, Photon | 6 | 2024 | 1738 | 1.800 |
Why?
|
Pregnancy Trimester, Second | 11 | 2024 | 730 | 1.750 |
Why?
|
American Heart Association | 7 | 2023 | 1039 | 1.670 |
Why?
|
Genome-Wide Association Study | 53 | 2024 | 12661 | 1.560 |
Why?
|
Insulin | 28 | 2024 | 6593 | 1.550 |
Why?
|
Pregnancy Complications | 19 | 2024 | 2948 | 1.520 |
Why?
|
Infant, Newborn | 85 | 2024 | 26183 | 1.490 |
Why?
|
Fetal Development | 15 | 2023 | 769 | 1.490 |
Why?
|
Prospective Studies | 80 | 2024 | 54364 | 1.390 |
Why?
|
Female | 283 | 2024 | 392203 | 1.370 |
Why?
|
Obesity | 40 | 2024 | 12934 | 1.330 |
Why?
|
Adipokines | 5 | 2024 | 308 | 1.310 |
Why?
|
Life Style | 16 | 2023 | 3907 | 1.210 |
Why?
|
Epigenomics | 15 | 2023 | 942 | 1.200 |
Why?
|
Metabolomics | 8 | 2024 | 1656 | 1.130 |
Why?
|
Hypertension, Pregnancy-Induced | 10 | 2024 | 517 | 1.080 |
Why?
|
Humans | 335 | 2024 | 760740 | 1.080 |
Why?
|
Child | 101 | 2024 | 80089 | 1.030 |
Why?
|
Adult | 144 | 2024 | 220995 | 0.970 |
Why?
|
Metabolome | 5 | 2024 | 988 | 0.970 |
Why?
|
Anti-Mullerian Hormone | 2 | 2024 | 407 | 0.940 |
Why?
|
Pregnant Women | 2 | 2021 | 567 | 0.930 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2024 | 4340 | 0.890 |
Why?
|
Receptor, IGF Type 1 | 2 | 2024 | 380 | 0.890 |
Why?
|
Polymorphism, Single Nucleotide | 33 | 2024 | 15908 | 0.890 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 127 | 0.880 |
Why?
|
Obesity, Abdominal | 3 | 2022 | 373 | 0.880 |
Why?
|
Infant Nutritional Physiological Phenomena | 3 | 2023 | 351 | 0.880 |
Why?
|
Waist Circumference | 11 | 2024 | 933 | 0.870 |
Why?
|
Pregnancy Trimester, First | 14 | 2024 | 908 | 0.860 |
Why?
|
Overweight | 12 | 2022 | 2417 | 0.850 |
Why?
|
Body Composition | 6 | 2024 | 2426 | 0.850 |
Why?
|
Child Development | 9 | 2023 | 2300 | 0.850 |
Why?
|
Polycystic Ovary Syndrome | 2 | 2024 | 376 | 0.840 |
Why?
|
Parturition | 4 | 2023 | 447 | 0.830 |
Why?
|
Genetic Predisposition to Disease | 24 | 2024 | 17878 | 0.810 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2018 | 344 | 0.810 |
Why?
|
Child, Preschool | 58 | 2024 | 42193 | 0.810 |
Why?
|
Pre-Eclampsia | 8 | 2024 | 1230 | 0.800 |
Why?
|
Mothers | 16 | 2023 | 2194 | 0.800 |
Why?
|
Menopause | 4 | 2024 | 1645 | 0.780 |
Why?
|
Glucose Intolerance | 10 | 2023 | 575 | 0.770 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2024 | 504 | 0.760 |
Why?
|
Resistin | 4 | 2010 | 172 | 0.750 |
Why?
|
Cohort Studies | 49 | 2024 | 41464 | 0.720 |
Why?
|
Male | 148 | 2024 | 360402 | 0.710 |
Why?
|
Maternal-Fetal Exchange | 5 | 2019 | 461 | 0.710 |
Why?
|
Cardiovascular Diseases | 15 | 2024 | 15498 | 0.700 |
Why?
|
Health Behavior | 8 | 2024 | 2643 | 0.700 |
Why?
|
Body Weight | 10 | 2021 | 4615 | 0.700 |
Why?
|
Maternal Exposure | 10 | 2024 | 1067 | 0.700 |
Why?
|
Adolescent | 67 | 2024 | 88247 | 0.700 |
Why?
|
Postpartum Period | 7 | 2024 | 1178 | 0.690 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2020 | 91 | 0.680 |
Why?
|
Blood Pressure | 10 | 2024 | 8473 | 0.670 |
Why?
|
Genotype | 17 | 2023 | 12977 | 0.670 |
Why?
|
Prediabetic State | 6 | 2024 | 545 | 0.670 |
Why?
|
Cesarean Section | 4 | 2024 | 1396 | 0.670 |
Why?
|
Abdominal Fat | 1 | 2021 | 221 | 0.660 |
Why?
|
Fructosamine | 1 | 2018 | 14 | 0.650 |
Why?
|
Hair | 5 | 2024 | 498 | 0.640 |
Why?
|
Receptors, LDL | 3 | 2019 | 488 | 0.640 |
Why?
|
Feeding Behavior | 7 | 2024 | 3183 | 0.630 |
Why?
|
Genetic Loci | 8 | 2020 | 2624 | 0.610 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2018 | 41 | 0.610 |
Why?
|
Glucose | 14 | 2024 | 4345 | 0.610 |
Why?
|
Pregnancy Outcome | 13 | 2024 | 2921 | 0.610 |
Why?
|
Gestational Age | 18 | 2023 | 3577 | 0.610 |
Why?
|
Pregnancy Trimesters | 4 | 2019 | 197 | 0.600 |
Why?
|
Intra-Abdominal Fat | 3 | 2020 | 612 | 0.590 |
Why?
|
Diet | 11 | 2024 | 8049 | 0.580 |
Why?
|
Child Behavior | 3 | 2024 | 848 | 0.580 |
Why?
|
Young Adult | 44 | 2024 | 59191 | 0.580 |
Why?
|
Hypotension | 1 | 2023 | 879 | 0.570 |
Why?
|
Adipose Tissue | 6 | 2015 | 3310 | 0.570 |
Why?
|
Mercury | 4 | 2022 | 290 | 0.570 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2018 | 361 | 0.560 |
Why?
|
Genetic Variation | 14 | 2019 | 6561 | 0.550 |
Why?
|
Metals | 5 | 2024 | 719 | 0.550 |
Why?
|
Insulin-Like Growth Factor II | 5 | 2021 | 268 | 0.550 |
Why?
|
Fasting | 10 | 2019 | 1603 | 0.550 |
Why?
|
Risk Reduction Behavior | 4 | 2020 | 1110 | 0.540 |
Why?
|
Diabetes Mellitus | 10 | 2023 | 5838 | 0.540 |
Why?
|
Glycemic Index | 1 | 2018 | 396 | 0.530 |
Why?
|
Hunger | 2 | 2024 | 205 | 0.530 |
Why?
|
Erythroblasts | 1 | 2016 | 142 | 0.530 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2017 | 174 | 0.530 |
Why?
|
Risk Factors | 53 | 2024 | 74128 | 0.520 |
Why?
|
Genomic Imprinting | 4 | 2021 | 329 | 0.510 |
Why?
|
Genetic Association Studies | 6 | 2021 | 2734 | 0.510 |
Why?
|
Preventive Medicine | 1 | 2017 | 245 | 0.490 |
Why?
|
Smoking | 10 | 2021 | 9054 | 0.490 |
Why?
|
Exercise | 10 | 2024 | 5886 | 0.490 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2019 | 3776 | 0.480 |
Why?
|
Linear Models | 11 | 2023 | 5866 | 0.480 |
Why?
|
Maternal Nutritional Physiological Phenomena | 3 | 2021 | 389 | 0.480 |
Why?
|
Hydrocortisone | 5 | 2024 | 1819 | 0.470 |
Why?
|
Parenting | 1 | 2020 | 702 | 0.470 |
Why?
|
Inservice Training | 1 | 2017 | 375 | 0.470 |
Why?
|
Metabolic Diseases | 6 | 2021 | 680 | 0.460 |
Why?
|
Genetic Markers | 3 | 2023 | 2601 | 0.460 |
Why?
|
Lipid Metabolism | 3 | 2020 | 1896 | 0.460 |
Why?
|
Ghrelin | 2 | 2017 | 251 | 0.450 |
Why?
|
Longitudinal Studies | 19 | 2024 | 14599 | 0.450 |
Why?
|
Quebec | 5 | 2024 | 140 | 0.440 |
Why?
|
Vitamin D Deficiency | 3 | 2024 | 1388 | 0.440 |
Why?
|
Maternal Age | 6 | 2024 | 809 | 0.440 |
Why?
|
Premature Birth | 6 | 2023 | 1782 | 0.430 |
Why?
|
Infant | 31 | 2024 | 36157 | 0.420 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2024 | 277 | 0.410 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2019 | 467 | 0.410 |
Why?
|
Health Promotion | 5 | 2022 | 2206 | 0.400 |
Why?
|
Hypersensitivity, Immediate | 3 | 2019 | 347 | 0.380 |
Why?
|
Caprylates | 4 | 2020 | 115 | 0.380 |
Why?
|
Prenatal Care | 2 | 2018 | 1140 | 0.380 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 4 | 2017 | 416 | 0.380 |
Why?
|
Goals | 1 | 2016 | 708 | 0.370 |
Why?
|
C-Peptide | 6 | 2024 | 440 | 0.370 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 825 | 0.370 |
Why?
|
Puberty | 4 | 2024 | 501 | 0.370 |
Why?
|
Cross-Sectional Studies | 20 | 2024 | 26065 | 0.370 |
Why?
|
Counseling | 2 | 2016 | 1538 | 0.360 |
Why?
|
Metformin | 2 | 2015 | 906 | 0.350 |
Why?
|
Cognition | 9 | 2023 | 6988 | 0.350 |
Why?
|
Micronutrients | 2 | 2023 | 381 | 0.340 |
Why?
|
Food Preferences | 3 | 2023 | 398 | 0.340 |
Why?
|
Quantitative Trait Loci | 5 | 2016 | 2112 | 0.340 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2012 | 393 | 0.340 |
Why?
|
Massachusetts | 17 | 2024 | 8835 | 0.340 |
Why?
|
MicroRNAs | 6 | 2022 | 3802 | 0.330 |
Why?
|
Breast Feeding | 4 | 2022 | 1355 | 0.330 |
Why?
|
Arsenic | 2 | 2024 | 362 | 0.320 |
Why?
|
Promoter Regions, Genetic | 2 | 2018 | 5780 | 0.320 |
Why?
|
Energy Metabolism | 2 | 2019 | 2878 | 0.320 |
Why?
|
Residence Characteristics | 5 | 2024 | 2092 | 0.320 |
Why?
|
Inflammation | 5 | 2024 | 10759 | 0.320 |
Why?
|
Pituitary-Adrenal System | 2 | 2022 | 553 | 0.310 |
Why?
|
Hypoglycemia | 1 | 2015 | 883 | 0.300 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4739 | 0.300 |
Why?
|
Mendelian Randomization Analysis | 6 | 2024 | 1007 | 0.300 |
Why?
|
Menarche | 2 | 2021 | 532 | 0.290 |
Why?
|
Interleukin-18 | 1 | 2009 | 250 | 0.290 |
Why?
|
Sexual Maturation | 2 | 2019 | 261 | 0.290 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2022 | 702 | 0.290 |
Why?
|
Bayes Theorem | 7 | 2024 | 2327 | 0.290 |
Why?
|
Hypoglycemic Agents | 5 | 2024 | 3085 | 0.290 |
Why?
|
Asthma | 7 | 2023 | 6234 | 0.290 |
Why?
|
Canada | 4 | 2024 | 2120 | 0.280 |
Why?
|
Nasal Mucosa | 2 | 2021 | 415 | 0.280 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3634 | 0.270 |
Why?
|
Depression | 5 | 2023 | 8132 | 0.270 |
Why?
|
Gene Expression Regulation | 7 | 2021 | 11874 | 0.270 |
Why?
|
Prenatal Diagnosis | 2 | 2021 | 1265 | 0.270 |
Why?
|
Infertility | 2 | 2024 | 654 | 0.260 |
Why?
|
Carbohydrate Metabolism | 3 | 2020 | 262 | 0.260 |
Why?
|
United States | 27 | 2024 | 72292 | 0.260 |
Why?
|
Sleep | 3 | 2024 | 4764 | 0.250 |
Why?
|
Endocrine Disruptors | 2 | 2019 | 264 | 0.250 |
Why?
|
Delivery, Obstetric | 3 | 2021 | 939 | 0.250 |
Why?
|
Body Height | 5 | 2024 | 1565 | 0.250 |
Why?
|
Lipoprotein Lipase | 2 | 2017 | 133 | 0.250 |
Why?
|
Metabolism | 2 | 2018 | 193 | 0.240 |
Why?
|
Lipids | 5 | 2024 | 3332 | 0.240 |
Why?
|
Chronic Disease | 2 | 2017 | 9310 | 0.240 |
Why?
|
Heart | 3 | 2024 | 4403 | 0.240 |
Why?
|
Risk Assessment | 10 | 2024 | 23974 | 0.240 |
Why?
|
Age Factors | 10 | 2024 | 18381 | 0.230 |
Why?
|
Metals, Heavy | 2 | 2024 | 148 | 0.230 |
Why?
|
Triglycerides | 6 | 2018 | 2459 | 0.230 |
Why?
|
Alkanesulfonates | 1 | 2023 | 15 | 0.220 |
Why?
|
Follow-Up Studies | 13 | 2021 | 39062 | 0.220 |
Why?
|
Middle Aged | 38 | 2024 | 220603 | 0.220 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2017 | 1932 | 0.220 |
Why?
|
Health Status | 6 | 2024 | 4076 | 0.220 |
Why?
|
Infant, Low Birth Weight | 3 | 2018 | 869 | 0.220 |
Why?
|
Electronic Health Records | 2 | 2012 | 4810 | 0.220 |
Why?
|
Glucocorticoids | 2 | 2023 | 2160 | 0.220 |
Why?
|
Gene Expression Profiling | 7 | 2024 | 9417 | 0.220 |
Why?
|
Coronary Artery Disease | 4 | 2020 | 6403 | 0.210 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3239 | 0.210 |
Why?
|
Executive Function | 3 | 2021 | 1391 | 0.210 |
Why?
|
Health Personnel | 1 | 2017 | 3333 | 0.210 |
Why?
|
Anthropometry | 5 | 2022 | 1338 | 0.210 |
Why?
|
Birth Order | 1 | 2023 | 95 | 0.210 |
Why?
|
Hormones | 2 | 2017 | 869 | 0.210 |
Why?
|
Principal Component Analysis | 2 | 2019 | 943 | 0.210 |
Why?
|
Educational Status | 4 | 2023 | 2509 | 0.210 |
Why?
|
Insulin-Secreting Cells | 2 | 2024 | 898 | 0.210 |
Why?
|
Body Size | 4 | 2022 | 463 | 0.210 |
Why?
|
Blood Cells | 2 | 2022 | 305 | 0.200 |
Why?
|
Incidence | 11 | 2024 | 21339 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4010 | 0.190 |
Why?
|
Attitude to Health | 2 | 2015 | 2025 | 0.190 |
Why?
|
Sudden Infant Death | 1 | 2024 | 292 | 0.190 |
Why?
|
Models, Genetic | 3 | 2021 | 3431 | 0.190 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12043 | 0.190 |
Why?
|
Vitamins | 3 | 2024 | 1635 | 0.190 |
Why?
|
Menopause, Premature | 1 | 2022 | 124 | 0.190 |
Why?
|
Trace Elements | 1 | 2022 | 195 | 0.190 |
Why?
|
Socioeconomic Factors | 5 | 2024 | 7805 | 0.180 |
Why?
|
Clinical Competence | 1 | 2016 | 4790 | 0.180 |
Why?
|
Methylmercury Compounds | 1 | 2021 | 103 | 0.180 |
Why?
|
Homeostasis | 3 | 2024 | 3321 | 0.170 |
Why?
|
Food Contamination | 1 | 2021 | 191 | 0.170 |
Why?
|
Trophoblasts | 1 | 2021 | 224 | 0.170 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2019 | 102 | 0.170 |
Why?
|
Selenium | 1 | 2022 | 417 | 0.170 |
Why?
|
Lead | 3 | 2023 | 879 | 0.170 |
Why?
|
Sphingolipids | 1 | 2021 | 173 | 0.160 |
Why?
|
Environment Design | 1 | 2021 | 173 | 0.160 |
Why?
|
Case-Control Studies | 11 | 2022 | 22153 | 0.160 |
Why?
|
Environmental Illness | 1 | 2019 | 34 | 0.160 |
Why?
|
Paternal Exposure | 1 | 2019 | 96 | 0.160 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5334 | 0.160 |
Why?
|
Crown-Rump Length | 1 | 2018 | 32 | 0.160 |
Why?
|
Parity | 4 | 2023 | 924 | 0.160 |
Why?
|
Respiratory Sounds | 2 | 2021 | 702 | 0.160 |
Why?
|
Weight Loss | 3 | 2019 | 2682 | 0.160 |
Why?
|
Pregnancy Trimester, Third | 2 | 2024 | 582 | 0.160 |
Why?
|
Satiation | 1 | 2019 | 82 | 0.160 |
Why?
|
Sex Factors | 6 | 2022 | 10549 | 0.160 |
Why?
|
Diet, Sodium-Restricted | 1 | 2020 | 291 | 0.160 |
Why?
|
Appetite Regulation | 1 | 2019 | 84 | 0.150 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 540 | 0.150 |
Why?
|
Europe | 7 | 2020 | 3415 | 0.150 |
Why?
|
Sickle Cell Trait | 1 | 2019 | 85 | 0.150 |
Why?
|
RecQ Helicases | 1 | 2018 | 53 | 0.150 |
Why?
|
Infant Formula | 1 | 2019 | 194 | 0.150 |
Why?
|
Ibuprofen | 1 | 2019 | 229 | 0.150 |
Why?
|
Likelihood Functions | 1 | 2021 | 991 | 0.150 |
Why?
|
DNA-Binding Proteins | 4 | 2019 | 9586 | 0.150 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2019 | 263 | 0.150 |
Why?
|
Placentation | 1 | 2018 | 78 | 0.150 |
Why?
|
Intelligence Tests | 1 | 2019 | 503 | 0.150 |
Why?
|
Anxiety | 3 | 2022 | 4573 | 0.150 |
Why?
|
Manganese | 1 | 2020 | 393 | 0.140 |
Why?
|
Term Birth | 1 | 2018 | 138 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7403 | 0.140 |
Why?
|
Environmental Exposure | 4 | 2021 | 4483 | 0.140 |
Why?
|
Checklist | 1 | 2024 | 827 | 0.140 |
Why?
|
Consensus | 3 | 2023 | 3117 | 0.140 |
Why?
|
Thinness | 1 | 2020 | 480 | 0.140 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2017 | 68 | 0.140 |
Why?
|
Phospholipids | 1 | 2021 | 787 | 0.140 |
Why?
|
Genome, Human | 4 | 2019 | 4421 | 0.140 |
Why?
|
Growth Disorders | 1 | 2021 | 634 | 0.140 |
Why?
|
Coronary Disease | 3 | 2012 | 5911 | 0.140 |
Why?
|
Electronic Mail | 1 | 2018 | 213 | 0.140 |
Why?
|
Patient Education as Topic | 1 | 2007 | 2315 | 0.140 |
Why?
|
Policy Making | 1 | 2020 | 541 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2018 | 214 | 0.140 |
Why?
|
Intelligence | 1 | 2022 | 923 | 0.140 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 488 | 0.130 |
Why?
|
Behavior Therapy | 1 | 2022 | 877 | 0.130 |
Why?
|
Adolescent Development | 1 | 2019 | 282 | 0.130 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2174 | 0.130 |
Why?
|
Erythrocytes | 3 | 2021 | 2410 | 0.130 |
Why?
|
Food Supply | 1 | 2022 | 539 | 0.130 |
Why?
|
Fetus | 3 | 2019 | 1862 | 0.130 |
Why?
|
Television | 1 | 2018 | 407 | 0.130 |
Why?
|
Primary Health Care | 2 | 2009 | 4677 | 0.130 |
Why?
|
Cardiomegaly | 1 | 2018 | 590 | 0.130 |
Why?
|
Cholesterol | 3 | 2019 | 2902 | 0.130 |
Why?
|
Social Responsibility | 1 | 2018 | 385 | 0.130 |
Why?
|
Preventive Health Services | 1 | 2020 | 566 | 0.130 |
Why?
|
Cluster Analysis | 2 | 2020 | 2703 | 0.130 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 393 | 0.130 |
Why?
|
Peptide Hormones | 1 | 2016 | 132 | 0.130 |
Why?
|
Acetaminophen | 1 | 2019 | 555 | 0.120 |
Why?
|
Boston | 5 | 2021 | 9313 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1745 | 0.120 |
Why?
|
Environment | 1 | 2021 | 1123 | 0.120 |
Why?
|
Postprandial Period | 1 | 2017 | 314 | 0.120 |
Why?
|
Time Factors | 5 | 2022 | 39908 | 0.120 |
Why?
|
Immunoglobulin E | 2 | 2019 | 1502 | 0.120 |
Why?
|
Diet, Mediterranean | 1 | 2022 | 738 | 0.120 |
Why?
|
Apolipoprotein B-100 | 1 | 2015 | 157 | 0.120 |
Why?
|
Phenotype | 9 | 2024 | 16572 | 0.120 |
Why?
|
Causality | 1 | 2021 | 1241 | 0.120 |
Why?
|
Public Health | 3 | 2024 | 2671 | 0.120 |
Why?
|
Hypertension | 4 | 2024 | 8532 | 0.120 |
Why?
|
Evidence-Based Medicine | 3 | 2023 | 3680 | 0.120 |
Why?
|
Age of Onset | 1 | 2022 | 3303 | 0.120 |
Why?
|
Organ Specificity | 2 | 2019 | 1964 | 0.120 |
Why?
|
Child Behavior Disorders | 1 | 2019 | 804 | 0.120 |
Why?
|
Granulocytes | 1 | 2016 | 551 | 0.120 |
Why?
|
Area Under Curve | 1 | 2018 | 1635 | 0.120 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2017 | 364 | 0.120 |
Why?
|
Research Design | 5 | 2024 | 6174 | 0.120 |
Why?
|
Subcutaneous Fat | 2 | 2015 | 393 | 0.120 |
Why?
|
Motor Activity | 2 | 2016 | 2714 | 0.110 |
Why?
|
Hypercholesterolemia | 1 | 2021 | 1141 | 0.110 |
Why?
|
Endocrinology | 1 | 2020 | 442 | 0.110 |
Why?
|
Calcium Channels, L-Type | 1 | 2015 | 242 | 0.110 |
Why?
|
Folic Acid | 4 | 2023 | 1323 | 0.110 |
Why?
|
Health Occupations | 1 | 2015 | 223 | 0.110 |
Why?
|
Zinc | 2 | 2024 | 687 | 0.110 |
Why?
|
Odds Ratio | 7 | 2022 | 9644 | 0.110 |
Why?
|
Community-Institutional Relations | 1 | 2015 | 206 | 0.110 |
Why?
|
Professional Competence | 1 | 2017 | 431 | 0.110 |
Why?
|
Regression Analysis | 2 | 2021 | 6339 | 0.110 |
Why?
|
Body Fat Distribution | 1 | 2015 | 245 | 0.110 |
Why?
|
Dietary Fats | 1 | 2021 | 1995 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2018 | 3606 | 0.110 |
Why?
|
Receptors, Gastrointestinal Hormone | 2 | 2010 | 39 | 0.110 |
Why?
|
Prevalence | 8 | 2024 | 15702 | 0.110 |
Why?
|
Lipodystrophy | 1 | 2014 | 145 | 0.110 |
Why?
|
Signal Transduction | 2 | 2015 | 23415 | 0.110 |
Why?
|
Aged | 18 | 2021 | 169092 | 0.110 |
Why?
|
Infant, Premature | 2 | 2020 | 2107 | 0.100 |
Why?
|
Repressor Proteins | 3 | 2021 | 2985 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2016 | 1597 | 0.100 |
Why?
|
Adult Children | 1 | 2013 | 103 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2019 | 6016 | 0.100 |
Why?
|
Dietary Proteins | 1 | 2017 | 951 | 0.100 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2013 | 311 | 0.100 |
Why?
|
Fetal Hemoglobin | 1 | 2014 | 346 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7390 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2020 | 5239 | 0.090 |
Why?
|
Food Hypersensitivity | 1 | 2019 | 726 | 0.090 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2013 | 557 | 0.090 |
Why?
|
Morbidity | 1 | 2016 | 1750 | 0.090 |
Why?
|
Receptor, Melatonin, MT2 | 2 | 2024 | 82 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3575 | 0.090 |
Why?
|
Societies, Medical | 3 | 2020 | 3901 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1133 | 0.090 |
Why?
|
Focus Groups | 1 | 2016 | 1409 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1509 | 0.090 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 7995 | 0.090 |
Why?
|
Blood Specimen Collection | 1 | 2012 | 238 | 0.090 |
Why?
|
Androgens | 1 | 2018 | 1285 | 0.090 |
Why?
|
Social Class | 1 | 2019 | 1993 | 0.090 |
Why?
|
Pilot Projects | 2 | 2018 | 8619 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2597 | 0.090 |
Why?
|
Computer Simulation | 2 | 2021 | 6233 | 0.090 |
Why?
|
Pregnancy in Diabetics | 1 | 2011 | 197 | 0.090 |
Why?
|
Carnitine O-Palmitoyltransferase | 2 | 2021 | 82 | 0.080 |
Why?
|
Social Support | 1 | 2019 | 2174 | 0.080 |
Why?
|
Postnatal Care | 1 | 2012 | 260 | 0.080 |
Why?
|
Vitamin D | 3 | 2024 | 3301 | 0.080 |
Why?
|
Mental Health | 2 | 2022 | 3253 | 0.080 |
Why?
|
Aging | 3 | 2024 | 8700 | 0.080 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2013 | 620 | 0.080 |
Why?
|
Waist-Hip Ratio | 3 | 2015 | 518 | 0.080 |
Why?
|
Cation Transport Proteins | 1 | 2011 | 327 | 0.080 |
Why?
|
DNA | 2 | 2020 | 7196 | 0.080 |
Why?
|
Health Education | 1 | 2015 | 1049 | 0.080 |
Why?
|
Menstrual Cycle | 2 | 2022 | 539 | 0.080 |
Why?
|
Parents | 2 | 2019 | 3563 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2252 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20077 | 0.080 |
Why?
|
Molecular Weight | 1 | 2010 | 2185 | 0.080 |
Why?
|
Atherosclerosis | 2 | 2015 | 3400 | 0.080 |
Why?
|
Fruit | 1 | 2013 | 1158 | 0.070 |
Why?
|
Vegetables | 1 | 2013 | 1192 | 0.070 |
Why?
|
Physicians, Family | 1 | 2009 | 348 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15250 | 0.070 |
Why?
|
Air Pollution | 1 | 2021 | 2355 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2565 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4408 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2896 | 0.070 |
Why?
|
Self Report | 3 | 2022 | 3727 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10203 | 0.070 |
Why?
|
Cell Lineage | 1 | 2015 | 2553 | 0.070 |
Why?
|
Algorithms | 2 | 2021 | 14024 | 0.060 |
Why?
|
Transcription Factors | 4 | 2019 | 12116 | 0.060 |
Why?
|
Qualitative Research | 1 | 2016 | 3017 | 0.060 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2378 | 0.060 |
Why?
|
Workplace | 2 | 2023 | 863 | 0.060 |
Why?
|
North America | 2 | 2019 | 1273 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4028 | 0.060 |
Why?
|
Netherlands | 2 | 2021 | 2222 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2358 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2024 | 80583 | 0.060 |
Why?
|
Health Services | 1 | 2009 | 751 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4512 | 0.060 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 160 | 0.060 |
Why?
|
Colon | 2 | 1983 | 1791 | 0.060 |
Why?
|
Translations | 1 | 2024 | 81 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3204 | 0.060 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2018 | 152 | 0.060 |
Why?
|
Alleles | 4 | 2018 | 6861 | 0.060 |
Why?
|
Sex Characteristics | 3 | 2022 | 2637 | 0.060 |
Why?
|
Exercise Therapy | 1 | 2011 | 929 | 0.060 |
Why?
|
Kynurenine | 1 | 2024 | 141 | 0.060 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1994 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2238 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3798 | 0.050 |
Why?
|
Kidney | 3 | 2024 | 7044 | 0.050 |
Why?
|
Health Policy | 1 | 2015 | 2682 | 0.050 |
Why?
|
Plants, Toxic | 1 | 1982 | 71 | 0.050 |
Why?
|
Tryptophan | 1 | 2024 | 482 | 0.050 |
Why?
|
Communication | 1 | 2016 | 3851 | 0.050 |
Why?
|
RNA, Messenger | 5 | 2016 | 12759 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8603 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2024 | 602 | 0.050 |
Why?
|
Gene Expression | 3 | 2022 | 7569 | 0.050 |
Why?
|
Quality of Life | 2 | 2020 | 13359 | 0.050 |
Why?
|
Cholesterol, HDL | 3 | 2013 | 1810 | 0.050 |
Why?
|
Metabolic Networks and Pathways | 2 | 2019 | 789 | 0.050 |
Why?
|
Software | 1 | 2015 | 4432 | 0.050 |
Why?
|
Models, Structural | 1 | 2021 | 340 | 0.050 |
Why?
|
Cadmium | 1 | 2022 | 214 | 0.050 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2021 | 141 | 0.050 |
Why?
|
Mediator Complex | 1 | 2021 | 106 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 390 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2896 | 0.050 |
Why?
|
Pedigree | 1 | 2008 | 4539 | 0.050 |
Why?
|
Biomedical Research | 3 | 2024 | 3426 | 0.050 |
Why?
|
Cytosine | 1 | 2022 | 211 | 0.050 |
Why?
|
Choline | 1 | 2022 | 515 | 0.050 |
Why?
|
Guanine | 1 | 2022 | 278 | 0.050 |
Why?
|
Skinfold Thickness | 1 | 2020 | 163 | 0.040 |
Why?
|
Mass Spectrometry | 2 | 2018 | 2189 | 0.040 |
Why?
|
Carbon | 1 | 2024 | 665 | 0.040 |
Why?
|
Smoke | 1 | 1982 | 236 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2024 | 1033 | 0.040 |
Why?
|
Eating | 1 | 2007 | 1535 | 0.040 |
Why?
|
Models, Biological | 2 | 2015 | 9461 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 793 | 0.040 |
Why?
|
European Union | 1 | 2021 | 157 | 0.040 |
Why?
|
Electric Impedance | 1 | 2024 | 751 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2022 | 290 | 0.040 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2022 | 361 | 0.040 |
Why?
|
Stochastic Processes | 1 | 2021 | 355 | 0.040 |
Why?
|
Republic of Belarus | 1 | 2019 | 38 | 0.040 |
Why?
|
Mexico | 1 | 2022 | 757 | 0.040 |
Why?
|
Scavenger Receptors, Class B | 1 | 2019 | 85 | 0.040 |
Why?
|
Patient Care Team | 1 | 2011 | 2515 | 0.040 |
Why?
|
Personnel, Hospital | 1 | 2022 | 285 | 0.040 |
Why?
|
Milk | 1 | 2022 | 442 | 0.040 |
Why?
|
China | 2 | 2017 | 2374 | 0.040 |
Why?
|
Oceania | 1 | 2018 | 16 | 0.040 |
Why?
|
Perception | 2 | 2019 | 1199 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2018 | 4611 | 0.040 |
Why?
|
Financial Management | 1 | 2020 | 160 | 0.040 |
Why?
|
Policy | 1 | 2022 | 506 | 0.040 |
Why?
|
Kv1.3 Potassium Channel | 1 | 2018 | 7 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12448 | 0.040 |
Why?
|
Phosphates | 1 | 2022 | 769 | 0.040 |
Why?
|
Fenofibrate | 1 | 2018 | 87 | 0.040 |
Why?
|
England | 1 | 2019 | 526 | 0.040 |
Why?
|
Puberty, Precocious | 1 | 2019 | 164 | 0.040 |
Why?
|
Gene Frequency | 2 | 2016 | 3601 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 469 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2024 | 1386 | 0.040 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2018 | 114 | 0.040 |
Why?
|
Expert Testimony | 1 | 2020 | 364 | 0.040 |
Why?
|
HMGA2 Protein | 1 | 2018 | 102 | 0.040 |
Why?
|
Mitosis | 1 | 1983 | 1187 | 0.040 |
Why?
|
Puerperal Disorders | 1 | 2020 | 300 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2018 | 315 | 0.040 |
Why?
|
Seasons | 1 | 2023 | 1518 | 0.040 |
Why?
|
Health Plan Implementation | 1 | 2020 | 335 | 0.040 |
Why?
|
Aryldialkylphosphatase | 1 | 2017 | 64 | 0.030 |
Why?
|
Beverages | 1 | 2022 | 821 | 0.030 |
Why?
|
Students | 1 | 2007 | 1736 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2022 | 802 | 0.030 |
Why?
|
Seafood | 1 | 2020 | 393 | 0.030 |
Why?
|
Environmental Pollution | 1 | 2018 | 124 | 0.030 |
Why?
|
Cattle | 1 | 2022 | 3841 | 0.030 |
Why?
|
Patient Compliance | 1 | 2007 | 2688 | 0.030 |
Why?
|
Norway | 1 | 2017 | 499 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2022 | 1148 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 719 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 865 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 370 | 0.030 |
Why?
|
Genetic Testing | 1 | 2009 | 3533 | 0.030 |
Why?
|
Internationality | 1 | 2022 | 1000 | 0.030 |
Why?
|
Vital Capacity | 1 | 2019 | 971 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1381 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2475 | 0.030 |
Why?
|
Arteries | 1 | 2021 | 1120 | 0.030 |
Why?
|
Adolescent Behavior | 1 | 2024 | 1188 | 0.030 |
Why?
|
Animals | 7 | 2022 | 168202 | 0.030 |
Why?
|
Risk | 2 | 2018 | 9603 | 0.030 |
Why?
|
History, 21st Century | 1 | 2022 | 1566 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2018 | 293 | 0.030 |
Why?
|
Telomere | 1 | 2021 | 942 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1249 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1064 | 0.030 |
Why?
|
Malnutrition | 1 | 2022 | 622 | 0.030 |
Why?
|
Prognosis | 3 | 2021 | 29601 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2015 | 72 | 0.030 |
Why?
|
Microvessels | 1 | 2019 | 577 | 0.030 |
Why?
|
Growth | 1 | 2017 | 365 | 0.030 |
Why?
|
Meta-Analysis as Topic | 2 | 2010 | 1380 | 0.030 |
Why?
|
Intestinal Mucosa | 2 | 1983 | 3031 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2018 | 982 | 0.030 |
Why?
|
Cell Division | 1 | 1982 | 4457 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1725 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 1814 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2016 | 520 | 0.030 |
Why?
|
Collagen | 1 | 1982 | 2634 | 0.030 |
Why?
|
Introns | 1 | 2016 | 968 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2022 | 1490 | 0.030 |
Why?
|
Logistic Models | 1 | 2008 | 13248 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1300 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2020 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2024 | 1846 | 0.030 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2012 | 43 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2013 | 163 | 0.030 |
Why?
|
Mitotic Index | 2 | 1983 | 162 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 366 | 0.020 |
Why?
|
Somatomedins | 1 | 2012 | 179 | 0.020 |
Why?
|
Models, Organizational | 1 | 2015 | 544 | 0.020 |
Why?
|
Body Patterning | 1 | 2016 | 632 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58919 | 0.020 |
Why?
|
Glycosylation | 1 | 2014 | 1098 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2017 | 820 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1977 | 0.020 |
Why?
|
Cleft Lip | 1 | 2016 | 506 | 0.020 |
Why?
|
Actins | 1 | 2018 | 2051 | 0.020 |
Why?
|
Preconception Care | 1 | 2011 | 141 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1419 | 0.020 |
Why?
|
Cleft Palate | 1 | 2016 | 589 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 2013 | 625 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 2014 | 836 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2016 | 1340 | 0.020 |
Why?
|
Fatty Acid Desaturases | 1 | 2010 | 100 | 0.020 |
Why?
|
Program Development | 1 | 2016 | 1293 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2010 | 138 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15829 | 0.020 |
Why?
|
Models, Animal | 1 | 2016 | 2108 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1360 | 0.020 |
Why?
|
Proteins | 2 | 2018 | 6030 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7236 | 0.020 |
Why?
|
Particulate Matter | 1 | 2021 | 2602 | 0.020 |
Why?
|
Incretins | 1 | 2010 | 99 | 0.020 |
Why?
|
Diet Surveys | 1 | 2012 | 1161 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3619 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2851 | 0.020 |
Why?
|
Adipocytes | 1 | 2015 | 1187 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2021 | 4937 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2015 | 1349 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1890 | 0.020 |
Why?
|
Denmark | 1 | 2010 | 770 | 0.020 |
Why?
|
Professional Practice | 1 | 2009 | 313 | 0.020 |
Why?
|
Privacy | 1 | 2009 | 233 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10507 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7050 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 2011 | 589 | 0.020 |
Why?
|
Heart Diseases | 1 | 2019 | 2778 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 4987 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3415 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 1315 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2009 | 675 | 0.020 |
Why?
|
Antigens, CD | 1 | 2014 | 3998 | 0.010 |
Why?
|
Patients | 1 | 2009 | 906 | 0.010 |
Why?
|
Program Evaluation | 1 | 2011 | 2486 | 0.010 |
Why?
|
Methods | 1 | 1983 | 1065 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1982 | 151 | 0.010 |
Why?
|
Autoradiography | 1 | 1983 | 728 | 0.010 |
Why?
|
Medicine | 1 | 2009 | 942 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7583 | 0.010 |
Why?
|
Hemoglobin A | 1 | 1980 | 84 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2413 | 0.010 |
Why?
|
Mathematics | 1 | 1982 | 707 | 0.010 |
Why?
|
Proline | 1 | 1982 | 455 | 0.010 |
Why?
|
Glycosides | 1 | 1980 | 100 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3316 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1982 | 218 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 64572 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2803 | 0.010 |
Why?
|
Motivation | 1 | 2009 | 2003 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4242 | 0.010 |
Why?
|
Mice | 2 | 1983 | 81368 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5493 | 0.010 |
Why?
|
Computational Biology | 1 | 2009 | 3509 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1982 | 2100 | 0.010 |
Why?
|
Cell Cycle | 1 | 1983 | 2929 | 0.010 |
Why?
|
Databases, Factual | 1 | 2009 | 7963 | 0.010 |
Why?
|
Fibroblasts | 1 | 1982 | 4140 | 0.010 |
Why?
|
Peptides | 1 | 1980 | 4354 | 0.000 |
Why?
|